| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 09/15/2023 | 20.54% | Barclays | $14 → $12 | Maintains | Equal-Weight |
| 09/14/2023 | 201.36% | Maxim Group | → $30 | Reiterates | Buy → Buy |
| 09/14/2023 | 10.5% | Stifel | $13 → $11 | Maintains | Hold |
| 08/28/2023 | 30.59% | Evercore ISI Group | $14 → $13 | Maintains | In-Line |
| 08/28/2023 | 10.5% | JP Morgan | $14 → $11 | Maintains | Neutral |
| 08/25/2023 | 30.59% | Stifel | $16 → $13 | Maintains | Hold |
| 08/25/2023 | 20.54% | Mizuho | $14 → $12 | Maintains | Neutral |
| 07/20/2023 | 40.63% | Barclays | $17 → $14 | Maintains | Equal-Weight |
| 06/23/2023 | 70.77% | Stephens & Co. | → $17 | Initiates Coverage On | → Overweight |
| 05/11/2023 | 70.77% | Barclays | $19 → $17 | Maintains | Equal-Weight |
| 05/10/2023 | 131.04% | Bernstein | $30 → $23 | Maintains | Outperform |
| 05/10/2023 | 60.72% | Piper Sandler | $17 → $16 | Upgrades | Underweight → Neutral |
| 02/08/2023 | 60.72% | Mizuho | → $16 | Maintains | Neutral |
| 02/08/2023 | 110.95% | JP Morgan | $22 → $21 | Downgrades | Overweight → Neutral |
| 02/08/2023 | 70.77% | Piper Sandler | $19 → $17 | Downgrades | Neutral → Underweight |
| 01/26/2023 | 90.86% | Piper Sandler | $18 → $19 | Maintains | Neutral |
| 12/20/2022 | 70.77% | Stifel | → $17 | Initiates Coverage On | → Hold |
| 12/02/2022 | 141.08% | Evercore ISI Group | $30 → $24 | Downgrades | Outperform → In-Line |
| 11/09/2022 | 80.81% | Mizuho | $16 → $18 | Maintains | Neutral |
| 10/21/2022 | 70.77% | Piper Sandler | $23 → $17 | Downgrades | Overweight → Neutral |
| 09/19/2022 | 141.08% | Piper Sandler | $27 → $24 | Maintains | Overweight |
| 08/29/2022 | 131.04% | Consumer Edge Research | $30 → $23 | Downgrades | Overweight → Equal-Weight |
| 08/26/2022 | 321.9% | Maxim Group | $50 → $42 | Maintains | Buy |
| 08/26/2022 | 171.22% | Piper Sandler | $28 → $27 | Maintains | Overweight |
| 08/19/2022 | 181.27% | Piper Sandler | $31 → $28 | Maintains | Overweight |
| 06/16/2022 | 211.4% | Piper Sandler | $36 → $31 | Maintains | Overweight |
| 05/24/2022 | 251.58% | CL King | → $35 | Initiates Coverage On | → Buy |
| 05/23/2022 | 241.54% | Cowen & Co. | → $34 | Initiates Coverage On | → Outperform |
| 05/09/2022 | 211.4% | Mizuho | $44 → $31 | Maintains | Buy |
| 05/03/2022 | 341.99% | Mizuho | $47 → $44 | Maintains | Buy |
| 02/08/2022 | — | Consumer Edge Research | Upgrades | Equal-Weight → Overweight | |
| 02/04/2022 | 432.4% | CFRA | $55 → $53 | Maintains | Buy |
| 01/27/2022 | 372.12% | Mizuho | → $47 | Initiates Coverage On | → Buy |
| 11/18/2021 | 382.17% | Evercore ISI Group | $46 → $48 | Upgrades | In-Line → Outperform |
| 02/10/2021 | 402.26% | Piper Sandler | $42 → $50 | Upgrades | Neutral → Overweight |
| 01/13/2021 | — | Evercore ISI Group | Downgrades | Outperform → In-Line | |
| 12/16/2020 | 331.94% | JP Morgan | $35 → $43 | Upgrades | Neutral → Overweight |
| 10/05/2020 | 271.67% | R5 Capital | → $37 | Initiates Coverage On | → Hold |
| 09/17/2020 | — | Truist Securities | Upgrades | Hold → Buy | |
| 09/08/2020 | 281.72% | Seaport Global | → $38 | Initiates Coverage On | → Buy |
| 08/26/2020 | 281.72% | Evercore ISI Group | $35 → $38 | Upgrades | In-Line → Outperform |
| 05/19/2020 | 261.63% | Bernstein | → $36 | Upgrades | Market Perform → Outperform |
| 05/08/2020 | 151.13% | SunTrust Robinson Humphrey | $23 → $25 | Maintains | Hold |
| 05/08/2020 | 181.27% | JP Morgan | $26 → $28 | Upgrades | Underweight → Neutral |
| 05/04/2020 | 151.13% | Wells Fargo | $26 → $25 | Maintains | Equal-Weight |
| 04/17/2020 | 161.18% | JP Morgan | $24 → $26 | Maintains | Underweight |
| 01/23/2020 | 191.31% | Jefferies | → $29 | Initiates Coverage On | → Hold |
| 12/31/2019 | 201.36% | Jefferies | $25 → $30 | Maintains | Buy |
| 12/02/2019 | 191.31% | Citigroup | $25 → $29 | Maintains | Buy |
| 11/12/2019 | 151.13% | Wells Fargo | $20 → $25 | Maintains | Market Perform |
| 09/24/2019 | 151.13% | Citigroup | $29 → $25 | Maintains | Buy |
| 08/30/2019 | 90.86% | Barclays | $23 → $19 | Maintains | Equal-Weight |
| 08/20/2019 | 80.81% | JP Morgan | $23 → $18 | Downgrades | Neutral → Underweight |
| 06/12/2019 | 120.99% | Evercore ISI Group | → $22 | Initiates Coverage On | → In-Line |
| 04/01/2019 | 131.04% | JP Morgan | $20 → $23 | Downgrades | Overweight → Neutral |
| 03/01/2019 | — | Bernstein | Downgrades | Outperform → Market Perform | |
| 02/28/2019 | 100.9% | JP Morgan | $15 → $20 | Upgrades | Neutral → Overweight |
| 12/17/2018 | 131.04% | BMO Capital | $25 → $23 | Maintains | Market Perform |
What is the target price for Hain Celestial Group (HAIN)?
The latest price target for Hain Celestial Group (NASDAQ: HAIN) was reported by Barclays on September 15, 2023. The analyst firm set a price target for $12.00 expecting HAIN to rise to within 12 months (a possible 20.54% upside). 21 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Hain Celestial Group (HAIN)?
The latest analyst rating for Hain Celestial Group (NASDAQ: HAIN) was provided by Barclays, and Hain Celestial Group maintained their equal-weight rating.
When is the next analyst rating going to be posted or updated for Hain Celestial Group (HAIN)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Hain Celestial Group, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Hain Celestial Group was filed on September 15, 2023 so you should expect the next rating to be made available sometime around September 15, 2024.
Is the Analyst Rating Hain Celestial Group (HAIN) correct?
While ratings are subjective and will change, the latest Hain Celestial Group (HAIN) rating was a maintained with a price target of $14.00 to $12.00. The current price Hain Celestial Group (HAIN) is trading at is $9.96, which is out of the analyst's predicted range.